MoneyWorks4Me

Strides Shasun informs about company updates

03 Nov 2016 Evaluate

Strides Shasun has informed that Strides and Mylan agree to settle Regulatory and General Claims on Agila transaction. After payment to Mylan, Strides to receive approximately $30 Million from Regulatory escrow.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

977.00 8.95 (0.92%)
17-Aug-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.70
Dr. Reddys Labs. 1195.15
Cipla 1432.35
Lupin 2225.00
Zydus Lifesciences 1144.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: